首页> 外国专利> Hybrid plasmid pzzsa coding the synthesis of angiogenis of angiogenin protein and escherichia coli bl21(des) pzzsa strain as the the superoducer of the recombinant chimeric protein of human angiogenin

Hybrid plasmid pzzsa coding the synthesis of angiogenis of angiogenin protein and escherichia coli bl21(des) pzzsa strain as the the superoducer of the recombinant chimeric protein of human angiogenin

机译:编码质粒合成血管生成素和大肠杆菌bl21(des)pzzsa菌株的合成的质粒pzzsa作为人血管生成素重组嵌合蛋白的超诱导剂

摘要

The invention relates to biotechnology and enhances the expression efficiency of the hybrid gene and stability of the angiogenin protein, as well as provides a possibility of affinity purification of chimeric protein on IgG sorbents. ;The hybrid plasmid pZZSA with a molecular weight of 3.814 megadalton (MDa) (6192 bp) which drives the synthesis of the chimeric protein of angiogenin is disclosed, comprising an XhoI/EcoRI fragment of the pGM280 plasmid DNA comprising a tandem of E. coli tryptophan operon promoters, a lambda phage transcription terminator, a β-lactamase gene and an ori replication initiation site; an EcoRI/EcoNI fragment of the PfM plasmid comprising a synthetic translation enhancer of the bacteriophage T7 gene and gene Ap coding for the amino acid sequence corresponding to 3988-4845 bp; synthetic chimeric angiogenin gene (Ang) fused with Spa; unique recognition sites for restriction nucleases. ;The strain Escherichia coli BL21 (DE3) pZZSA (the Collection of Microorganisms of the Interregional Center for Human Microcenosis Correction, Novosibirsk, Registration No. MCKM B-127) that is the superproducer of recombinant chimeric protein of human angiogenin is described.
机译:本发明涉及生物技术,并提高了杂交基因的表达效率和血管生成素蛋白的稳定性,并提供了在IgG吸附剂上亲和纯化嵌合蛋白的可能性。公开了一种分子量为3.814兆尔顿(MDa)(6192bp)的杂合质粒pZZSA,其驱动血管生成素的嵌合蛋白的合成,其包含pGM280质粒DNA的XhoI / EcoRI片段,其包含串联的。 E.大肠杆菌色氨酸操纵子启动子,λ噬菌体转录终止子,β-内酰胺酶基因和一个ori复制起始位点; PfM质粒的EcoRI / EcoNI片段,其包含噬菌体T7基因的合成翻译增强子和编码对应于3988-4845 bp的氨基酸序列的基因Ap;与Spa融合的合成嵌合血管生成素基因(Ang);限制性核酸酶的独特识别位点。 ; 大肠杆菌 BL21(DE3)pZZSA菌株(新西伯利亚人际微生物校正中心间微生物中心,新西伯利亚,注册号MCKM B-127),是重组嵌合蛋白的生产者。描述了人血管生成素。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号